ES2120961T3 - Composicion anti-trombogena y/o anti-microbiana. - Google Patents
Composicion anti-trombogena y/o anti-microbiana.Info
- Publication number
- ES2120961T3 ES2120961T3 ES91909862T ES91909862T ES2120961T3 ES 2120961 T3 ES2120961 T3 ES 2120961T3 ES 91909862 T ES91909862 T ES 91909862T ES 91909862 T ES91909862 T ES 91909862T ES 2120961 T3 ES2120961 T3 ES 2120961T3
- Authority
- ES
- Spain
- Prior art keywords
- reacted
- quaternary ammonium
- ionic surfactants
- thrombogen
- antibiotics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000000845 anti-microbial effect Effects 0.000 title abstract 2
- 239000004599 antimicrobial Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000002563 ionic surfactant Substances 0.000 abstract 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 2
- 229940088710 antibiotic agent Drugs 0.000 abstract 2
- 229960002897 heparin Drugs 0.000 abstract 2
- 229920000669 heparin Polymers 0.000 abstract 2
- 239000008177 pharmaceutical agent Substances 0.000 abstract 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 abstract 2
- 230000002965 anti-thrombogenic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001453 quaternary ammonium group Chemical group 0.000 abstract 1
- 229920003176 water-insoluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
- A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
SE PRESENTAN COMPOSICIONES ANTITROMBOGENICAS, Y/O ANTIMICROBIANA Y/ FARMACEUTICA QUE CONTIENEN HEPARINA Y/O ANTIBIOTICOS Y/O OTROS AGENTES FARMACEUTICOS QUE PUEDEN SER REACCIONADOS CON COMPONENTES AMONIO CUATERNARIO U OTROS SURFACTANTES IONICOS Y ENLAZADO CON POLIMEROS HIDROSOLUBLES. TALES COMPOSICIONES TAMBIEN PUEDEN CONTENER COMPUESTOS DE AMONIO CUATERNARIO ADICIONALES U OTROS SURFACTANTES IONICOS NO REACCIONADOS CON HEPARINA Y PUEDEN TAMBIEN CONTENER COMPUESTO(S) DE AMONIO CUATERNARIO U OTROS SURFACTANTES IONICOS REACCIONADOS CON ANTIBIOTICOS U OTROS AGENTES FARMACEUTICOS IONICO O NO IONICOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55192490A | 1990-07-12 | 1990-07-12 | |
US66245291A | 1991-02-28 | 1991-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2120961T3 true ES2120961T3 (es) | 1998-11-16 |
Family
ID=27069899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91909862T Expired - Lifetime ES2120961T3 (es) | 1990-07-12 | 1991-05-02 | Composicion anti-trombogena y/o anti-microbiana. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0626854B1 (es) |
AT (1) | ATE168269T1 (es) |
CA (1) | CA2087102C (es) |
DE (1) | DE69129812T2 (es) |
DK (1) | DK0626854T3 (es) |
ES (1) | ES2120961T3 (es) |
WO (1) | WO1992000747A1 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT590348E (pt) * | 1992-09-26 | 2002-07-31 | Aventis Bulk S P A | Cateteres das veias centrais carregados com antibioticos de lipodalba-heptideo para impedir o desenvolvimento de infeccoes relacionadas com os cateteres |
US5994341A (en) * | 1993-07-19 | 1999-11-30 | Angiogenesis Technologies, Inc. | Anti-angiogenic Compositions and methods for the treatment of arthritis |
US5532311A (en) * | 1995-02-01 | 1996-07-02 | Minnesota Mining And Manufacturing Company | Process for modifying surfaces |
US5583213A (en) * | 1995-05-12 | 1996-12-10 | Minnesota Mining And Manufacturing Company | Process to activate sulfated polysaccharides |
WO1997029802A2 (en) | 1996-02-20 | 1997-08-21 | Advanced Bionics Corporation | Improved implantable microstimulator and systems employing the same |
US5916585A (en) * | 1996-06-03 | 1999-06-29 | Gore Enterprise Holdings, Inc. | Materials and method for the immobilization of bioactive species onto biodegradable polymers |
US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
US6495579B1 (en) | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
US6197289B1 (en) | 1997-07-01 | 2001-03-06 | Terumo Cardiovascular Systems Corporation | Removal of biologically active agents |
US5945457A (en) * | 1997-10-01 | 1999-08-31 | A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Science | Process for preparing biologically compatible polymers and their use in medical devices |
JP3228409B2 (ja) | 1997-12-05 | 2001-11-12 | 東洋紡績株式会社 | 血液適合性組成物および医療用具 |
KR100591027B1 (ko) * | 1997-12-26 | 2006-06-22 | 아스텔라스세이야쿠 가부시키가이샤 | 서방성 의약 조성물 |
US20040254635A1 (en) | 1998-03-30 | 2004-12-16 | Shanley John F. | Expandable medical device for delivery of beneficial agent |
US7208011B2 (en) | 2001-08-20 | 2007-04-24 | Conor Medsystems, Inc. | Implantable medical device with drug filled holes |
US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
ES2179646T3 (es) | 1998-04-27 | 2003-01-16 | Surmodics Inc | Revestimiento que libera un agente bioactivo. |
IL142131A0 (en) | 1998-09-23 | 2002-03-10 | Phycogen Inc | Environmentally benign crop protection agents |
US6120847A (en) * | 1999-01-08 | 2000-09-19 | Scimed Life Systems, Inc. | Surface treatment method for stent coating |
US6419692B1 (en) | 1999-02-03 | 2002-07-16 | Scimed Life Systems, Inc. | Surface protection method for stents and balloon catheters for drug delivery |
US6156373A (en) | 1999-05-03 | 2000-12-05 | Scimed Life Systems, Inc. | Medical device coating methods and devices |
JP2004511297A (ja) | 2000-10-16 | 2004-04-15 | コナー メドシステムズ, インコーポレイテッド | 有益な薬剤を搬送するための拡張可能な医療装置 |
DE60231209D1 (de) * | 2001-06-05 | 2009-04-02 | Toyo Boseki | Antithrombotische zusammensetzungen und diese enthaltende medizinische instrumente |
US7056338B2 (en) | 2003-03-28 | 2006-06-06 | Conor Medsystems, Inc. | Therapeutic agent delivery device with controlled therapeutic agent release rates |
US20050244459A1 (en) | 2004-04-06 | 2005-11-03 | Dewitt David M | Coating compositions for bioactive agents |
USD516723S1 (en) | 2004-07-06 | 2006-03-07 | Conor Medsystems, Inc. | Stent wall structure |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4127647A (en) * | 1975-04-08 | 1978-11-28 | Meiji Seika Kaisha, Ltd. | Process for preparation of stable amorphous macrolide antibiotic solids |
US4871357A (en) * | 1986-01-21 | 1989-10-03 | Baxter International Inc. | Ionic heparin coating |
AU2902289A (en) * | 1987-12-08 | 1989-07-05 | Mark Chasin | Method of forming bioerodible implants for improved controlled drug release |
US5019096A (en) * | 1988-02-11 | 1991-05-28 | Trustees Of Columbia University In The City Of New York | Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same |
US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
-
1991
- 1991-05-02 DE DE69129812T patent/DE69129812T2/de not_active Expired - Fee Related
- 1991-05-02 CA CA002087102A patent/CA2087102C/en not_active Expired - Fee Related
- 1991-05-02 WO PCT/US1991/002868 patent/WO1992000747A1/en active IP Right Grant
- 1991-05-02 DK DK91909862T patent/DK0626854T3/da active
- 1991-05-02 EP EP91909862A patent/EP0626854B1/en not_active Expired - Lifetime
- 1991-05-02 AT AT91909862T patent/ATE168269T1/de not_active IP Right Cessation
- 1991-05-02 ES ES91909862T patent/ES2120961T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0626854A4 (en) | 1993-09-02 |
DE69129812T2 (de) | 1999-02-11 |
ATE168269T1 (de) | 1998-08-15 |
EP0626854A1 (en) | 1994-12-07 |
EP0626854B1 (en) | 1998-07-15 |
DE69129812D1 (de) | 1998-08-20 |
CA2087102A1 (en) | 1992-01-13 |
CA2087102C (en) | 2002-04-23 |
WO1992000747A1 (en) | 1992-01-23 |
DK0626854T3 (da) | 1999-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2120961T3 (es) | Composicion anti-trombogena y/o anti-microbiana. | |
DE69109351D1 (de) | Antimikrobielle Zusammensetzung. | |
PH31670A (en) | Anti-microbial compositions. | |
DE69109192D1 (de) | Detergenszusammensetzungen. | |
DE69109193D1 (de) | Detergenszusammensetzungen. | |
DE69103696D1 (de) | Netzmittel. | |
DE69114149D1 (de) | Detergentzusammensetzung. | |
TR28023A (tr) | Yüzeyaktif iyon cifti floresanli beyazlatici terkipleri. | |
DK0533017T3 (da) | Vandbaserede, opløsningsmiddel- og emulgatorfrie mikrobicide kombinationer af aktive stoffer | |
DE69105870D1 (de) | Kationische Verbindung und Reinigungsmittelzusammensetzung. | |
ITFI930083A0 (it) | Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono. | |
DE69111436D1 (de) | Zusammensetzungen von flüssigen, milden geschirrspülmitteln. | |
DE69112970D1 (de) | Nichtionische pulverförmige Detergentzusammensetzung. | |
DE69113496D1 (de) | Polymerzusammensetzungen. | |
DE69021872D1 (de) | Modifizierte Lösungsmittelzusammensetzungen. | |
DE69102535D1 (de) | Beschichtungszusammensetzung. | |
DE69104160D1 (de) | Netzmittel. | |
DE69112712D1 (de) | Waschmittelzusammensetzung. | |
NO900612D0 (no) | Preservativ for vandige sammensetninger. | |
ES2099087T3 (es) | Composicion anti-trombogena y/o antimicrobiana. | |
NO912598D0 (no) | Hypokalori-matsammensetning. | |
NO902745L (no) | Fiberkondisjoneringsblandinger inneholdende aminosilikon-kondisjoneringsmiddel. | |
BR9101255A (pt) | Composto,composicao e processo fungicida,composicao e processo inseticida ou acaricida | |
IT1243389B (it) | Derivati poliaminopirrolcarbossiamidici, processi di preparazione e composizioni farmaceutiche che li contengono. | |
DE69004283D1 (de) | Tensidzusammensetzung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 626854 Country of ref document: ES |